Introduction
The document discusses the use of CO2 laser technology for stimulating Laser Evoked Potentials (LEPs) in neurophysiology. This technology has transformed the study of pain by selectively activating nociceptors without affecting non-nociceptive afferents, which is a limitation of electrical stimuli.

Specifications and Advantages
The CO2 laser stimulator is compact, practical, and easy to use, providing quick assessments of the nociceptive system. It is widely used in clinical neurophysiology for various pain assessments. The YAP laser allows for easy stimulation of different body areas and can be used in shielded environments like MRI and MEG rooms.

Neurolas System
The Neurolas system uses an articulated arm with high mechanical accuracy to deliver CO2 laser radiation. It allows for adjustments in stimulus amplitude, duration, and energy density. The system is compatible with electromyographs and controlled by a microprocessor, ensuring high repeatability and minimal latency.

Clinical Applications
LEPs are useful in diagnosing and assessing various pain syndromes, including neuropathic pain, trigeminal neuralgia, and fibromyalgia. The technology is considered reliable for assessing the nociceptive pathway from skin to cerebral cortex.

Technical Data
The document provides technical specifications for the laser systems, including wavelength, peak power, pulse length, and transmission systems. The CO2 laser operates at 1064nm with a maximum power of 15W, while the ND:Yap laser operates at 1340nm with a peak power of 750W.

Safety and Standards
The laser devices are classified as Class 4, with safety measures to avoid direct or diffuse exposure to laser radiation. They comply with EN 60825-1 standards and are manufactured under ISO 9001 and ISO 13485 quality assurance systems.

Conclusion
DEKA, a leader in laser technology, manufactures these devices, ensuring quality and innovation in the medical field. The CO2 laser technology for LEPs offers a significant advancement in pain study and management.